Abbott
Abbott Laboratories, commonly known as Abbott, is a global healthcare company headquartered in Abbott Park, Illinois, USA. Founded in 1888, Abbott has established itself as a leader in the healthcare industry, with significant operations across North America, Europe, Asia, and Latin America. The company focuses on various business areas, including diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott is renowned for its innovative core products, such as the FreeStyle Libre glucose monitoring system and Similac infant formula, which set benchmarks in their respective markets. With a commitment to advancing health and well-being, Abbott has achieved notable milestones, including the rapid development of COVID-19 testing solutions. As a trusted name in healthcare, Abbott continues to enhance its market position through cutting-edge research and a dedication to improving patient outcomes worldwide.
DitchCarbon Score
How does Abbott's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott's score of 66 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abbott's reported carbon emissions
In 2023, Abbott reported total greenhouse gas emissions of approximately 510,000 tonnes CO2e from Scope 1 and 2 sources, with an additional 11 million tonnes CO2e attributed to fugitive emissions. The company has set ambitious targets to reduce its absolute Scope 1 and 2 emissions by 30% by 2030, using 2018 as the baseline year. This commitment aligns with the Science Based Targets initiative (SBTi) and includes a goal for 82% of its suppliers, based on emissions from purchased goods and services and upstream transportation, to establish their own science-based targets by 2026. Abbott's emissions data highlights a significant focus on sustainability within the healthcare sector, with a commitment to reducing its carbon footprint while ensuring that its operations remain efficient and environmentally responsible. The company is actively working towards these targets, which encompass land-related emissions and removals from bioenergy feedstocks, demonstrating a comprehensive approach to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 569,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 668,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abbott is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
